UTZ Utz Brands, Inc.
Miscellaneous Food Preparations & Kindred Products · NYSE · SEC CIK 1739566 · Fiscal year ends 01/03
Financial factors as of 2026-09-27 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY0.5%
TTM net income YoY-789.3%
TTM EPS YoY-728.6%
Revenue 3-yr CAGR0.1%
Net income 3-yr CAGR—
Margins
Gross margin24.6%
Operating margin-1.1%
Net margin-2.7%
FCF margin0.2%
EBITDA margin3.9%
Returns
ROE-5.5%
ROA-1.4%
ROIC (approx.)-0.8%
Asset turnover0.52x
Leverage & solvency
Liabilities / assets53.8%
Debt / equity1.30x
Current ratio1.07x
Interest coverage-0.37x
Cash quality & payout
Operating cash flow / net income-1.54x
Accruals ratio-3.5%
Payout ratio—
Capex / revenue4.0%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-28 | FY20242024-12-29 |
|---|---|---|
| Income statement | ||
| Revenue | $1.44B | $1.41B |
| Cost of revenue | $1.08B | $1.04B |
| Gross profit | $358.30M | $369.10M |
| SG&A expense | $348.00M | $310.10M |
| Operating income | $19.50M | $58.90M |
| Interest expense | $43.10M | $44.90M |
| Pretax income | -$600,000 | $69.40M |
| Income tax | $7.10M | $38.70M |
| Net income | $800,000 | $15.90M |
| EBITDA | $101.90M | $129.80M |
| EPS (basic) | 0.01 | 0.19 |
| EPS (diluted) | 0.01 | 0.19 |
| Weighted avg. shares (diluted) | 87.77M | 85.43M |
| Balance sheet | ||
| Cash & equivalents | $120.40M | $56.10M |
| Receivables | $100.80M | $119.90M |
| Inventory | $119.30M | $101.40M |
| Current assets | $384.40M | $317.30M |
| PP&E, net | $379.20M | $345.20M |
| Goodwill | $865.20M | $865.20M |
| Intangibles | $963.90M | $996.50M |
| Total assets | $2.79B | $2.72B |
| Current liabilities | $323.20M | $285.30M |
| Short-term debt | $31.40M | $16.10M |
| Long-term debt | $818.20M | $752.50M |
| Total debt | $849.60M | $768.60M |
| Total liabilities | $1.45B | $1.34B |
| Shareholders' equity | $713.70M | $696.90M |
| Net debt | $729.20M | $712.50M |
| Cash flow statement | ||
| Operating cash flow | $112.20M | $106.20M |
| Capital expenditure | $102.80M | $98.60M |
| Free cash flow | $9.40M | $7.60M |
| Investing cash flow | -$86.90M | $75.00M |
| Financing cash flow | $39.00M | -$177.10M |
| Depreciation & amortization | $82.40M | $70.90M |
| Stock-based compensation | $17.10M | $18.30M |
| Dividends paid | $22.30M | $21.70M |
Free plan shows the latest 2 periods; Pro shows all 8 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.